Search research articles
Contact Us
Filters
Showing results (21-30 of 31) with videos related to
Page
of 4
Sort By:
Cancers
|
February 25, 2022
HSA-Binding Prodrugs-Based Nanoparticles Endowed with Chemo and Photo-Toxicity against Breast Cancer
Valentina Rapozzi, Francesca Moret, Luca Menilli, et al.
Frontiers in Chemistry
|
April 9, 2024
HSA-nanobinders crafted from bioresponsive prodrugs for combined cancer chemoimmunotherapy-an <i>in vitro</i> exploration
Matilde Tubertini, Luca Menilli, Celeste Milani, et al.
Frontiers in Chemistry
|
July 3, 2024
Corrigendum: HSA-nanobinders crafted from bioresponsive prodrugs for combined cancer chemoimmunotherapy-an <i>in vitro</i> exploration
Matilde Tubertini, Luca Menilli, Celeste Milani, et al.
Pharmaceutics
|
March 26, 2022
Two Beats One: Osteosarcoma Therapy with Light-Activated and Chemo-Releasing Keratin Nanoformulation in a Preclinical Mouse Model
Elisa Martella, Barbara Dozza, Claudia Ferroni, et al.
ACS Applied Materials & Interfaces
|
May 30, 2019
Noncovalent Functionalization of 2D Black Phosphorus with Fluorescent Boronic Derivatives of Pyrene for Probing and Modulating the Interaction with Molecular Oxygen
Margherita Bolognesi, Salvatore Moschetto, Mariachiara Trapani, et al.
Journal of Medicinal Chemistry
|
August 15, 2014
A new avenue toward androgen receptor pan-antagonists: C2 sterically hindered substitution of hydroxy-propanamides
Andrea Guerrini, Anna Tesei, Claudia Ferroni, et al.
Journal of Medicinal Chemistry
|
July 28, 2021
Nitric Oxide Photo-Donor Hybrids of Ciprofloxacin and Norfloxacin: A Shift in Activity from Antimicrobial to Anticancer Agents
Antonino Nicolò Fallica, Carla Barbaraci, Emanuele Amata, et al.
Journal of Medicinal Chemistry
|
March 9, 2017
1,4-Substituted Triazoles as Nonsteroidal Anti-Androgens for Prostate Cancer Treatment
Claudia Ferroni, Antonella Pepe, Yeong Sang Kim, et al.
European Journal of Medicinal Chemistry
|
August 28, 2015
Quinazolinedione SIRT6 inhibitors sensitize cancer cells to chemotherapeutics
Giovanna Sociali, Lauretta Galeno, Marco Daniele Parenti, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
May 29, 2024
The novel SMYD3 inhibitor EM127 impairs DNA repair response to chemotherapy-induced DNA damage and reverses cancer chemoresistance
Paola Sanese, Katia De Marco, Martina Lepore Signorile, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 31) with videos related to
Sort By:
Page
of 4
Cancers
|
February 25, 2022
HSA-Binding Prodrugs-Based Nanoparticles Endowed with Chemo and Photo-Toxicity against Breast Cancer
Valentina Rapozzi, Francesca Moret, Luca Menilli, et al.
Frontiers in Chemistry
|
April 9, 2024
HSA-nanobinders crafted from bioresponsive prodrugs for combined cancer chemoimmunotherapy-an <i>in vitro</i> exploration
Matilde Tubertini, Luca Menilli, Celeste Milani, et al.
Frontiers in Chemistry
|
July 3, 2024
Corrigendum: HSA-nanobinders crafted from bioresponsive prodrugs for combined cancer chemoimmunotherapy-an <i>in vitro</i> exploration
Matilde Tubertini, Luca Menilli, Celeste Milani, et al.
Pharmaceutics
|
March 26, 2022
Two Beats One: Osteosarcoma Therapy with Light-Activated and Chemo-Releasing Keratin Nanoformulation in a Preclinical Mouse Model
Elisa Martella, Barbara Dozza, Claudia Ferroni, et al.
ACS Applied Materials & Interfaces
|
May 30, 2019
Noncovalent Functionalization of 2D Black Phosphorus with Fluorescent Boronic Derivatives of Pyrene for Probing and Modulating the Interaction with Molecular Oxygen
Margherita Bolognesi, Salvatore Moschetto, Mariachiara Trapani, et al.
Journal of Medicinal Chemistry
|
August 15, 2014
A new avenue toward androgen receptor pan-antagonists: C2 sterically hindered substitution of hydroxy-propanamides
Andrea Guerrini, Anna Tesei, Claudia Ferroni, et al.
Journal of Medicinal Chemistry
|
July 28, 2021
Nitric Oxide Photo-Donor Hybrids of Ciprofloxacin and Norfloxacin: A Shift in Activity from Antimicrobial to Anticancer Agents
Antonino Nicolò Fallica, Carla Barbaraci, Emanuele Amata, et al.
Journal of Medicinal Chemistry
|
March 9, 2017
1,4-Substituted Triazoles as Nonsteroidal Anti-Androgens for Prostate Cancer Treatment
Claudia Ferroni, Antonella Pepe, Yeong Sang Kim, et al.
European Journal of Medicinal Chemistry
|
August 28, 2015
Quinazolinedione SIRT6 inhibitors sensitize cancer cells to chemotherapeutics
Giovanna Sociali, Lauretta Galeno, Marco Daniele Parenti, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
May 29, 2024
The novel SMYD3 inhibitor EM127 impairs DNA repair response to chemotherapy-induced DNA damage and reverses cancer chemoresistance
Paola Sanese, Katia De Marco, Martina Lepore Signorile, et al.
Page
of 4